RxDoctor Payments Data

Glenn Goldman, MD

MOHS-Micrographic Surgery · Colchester, VTNPI 1992717458

Payments from drug & device makers

$2,820in general payments, 2019–2025

Across 1 payment — averaging $2820.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$3K

What the payments were for

  • Consulting fees$2,820100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron1$2,820

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few mohs-micrographic surgery providers in Vermontto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$605,490
Medicare patients
691
Services billed
2,925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcipotriene11$1,260
Fluorouracil13$709
Cephalexin237$670
Clobetasol Propionate14$605
Ketoconazole18$444

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →